Peter Molloy

2.1k total citations
18 papers, 808 citations indexed

About

Peter Molloy is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Molloy has authored 18 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Molloy's work include CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Cell Function and Interaction (7 papers). Peter Molloy is often cited by papers focused on CAR-T cell therapy research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Immune Cell Function and Interaction (7 papers). Peter Molloy collaborates with scholars based in United Kingdom, United States and Australia. Peter Molloy's co-authors include Bent K. Jakobsen, Annelise Vuidepot, William J. Harris, Nathaniel Liddy, Milos Aleksic, Kyong‐Mi Chang, Nick Pumphrey, Steven M. Dunn, Charles Cunningham and Andrew K. Sewell and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Cancer Research.

In The Last Decade

Peter Molloy

17 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Molloy United Kingdom 10 524 483 238 221 122 18 808
Annelise Vuidepot United Kingdom 14 745 1.4× 527 1.1× 228 1.0× 166 0.8× 121 1.0× 23 984
Nadine Bizouarne France 12 567 1.1× 338 0.7× 407 1.7× 134 0.6× 229 1.9× 17 834
Verena Rubio‐Godoy Switzerland 20 1.8k 3.4× 872 1.8× 644 2.7× 150 0.7× 71 0.6× 23 2.0k
Guillaume Stewart-Jones United Kingdom 8 591 1.1× 213 0.4× 262 1.1× 130 0.6× 30 0.2× 11 757
Sean C. Yoder United States 6 285 0.5× 202 0.4× 362 1.5× 472 2.1× 25 0.2× 11 712
Christina Furebring Sweden 13 287 0.5× 199 0.4× 211 0.9× 232 1.0× 19 0.2× 23 540
Thomas Meyer Germany 9 341 0.7× 299 0.6× 358 1.5× 34 0.2× 35 0.3× 13 722
Xuezhi Cao China 11 676 1.3× 243 0.5× 311 1.3× 44 0.2× 43 0.4× 16 929
Claudia Lemmel Germany 8 339 0.6× 106 0.2× 414 1.7× 101 0.5× 17 0.1× 11 559

Countries citing papers authored by Peter Molloy

Since Specialization
Citations

This map shows the geographic impact of Peter Molloy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Molloy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Molloy more than expected).

Fields of papers citing papers by Peter Molloy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Molloy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Molloy. The network helps show where Peter Molloy may publish in the future.

Co-authorship network of co-authors of Peter Molloy

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Molloy. A scholar is included among the top collaborators of Peter Molloy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Molloy. Peter Molloy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Friedland, Peter, Simon Tucker, Stephen Goodall, et al.. (2022). In vivo (human) and in vitro inactivation of SARS-CoV-2 with 0.5% povidone-iodine nasal spray. Australian Journal of Otolaryngology. 5. 0–0. 5 indexed citations
2.
Molloy, Peter. (2020). Ireland and the Waterloo Campaign of 1815. Maynooth University ePrints and eTheses Archive (Maynooth University). 1 indexed citations
3.
Yang, Hongli, Jakub Chojnacki, John Frater, et al.. (2017). Engineered affinity-enhanced immune-mobilising monoclonal T cell receptors (ImmTAVs) for HIV cure. HIV Medicine. 18. 7–7. 1 indexed citations
4.
Ojiro, Keisuke, Xiaowang Qu, Hyosun Cho, et al.. (2017). Modulation of Hepatitis C Virus-Specific CD8 Effector T-Cell Function with Antiviral Effect in Infectious Hepatitis C Virus Coculture Model. Journal of Virology. 91(10). 4 indexed citations
5.
Yang, Hongbing, Sandrine Buisson, Giovanna Bossi, et al.. (2016). Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors. Molecular Therapy. 24(11). 1913–1925. 31 indexed citations
6.
Bossi, Giovanna, Jane Harper, Joseph Dukes, et al.. (2015). ImmTACs: bi-specific TCR-anti-CD3 fusions for targeted tumour killing. Journal for ImmunoTherapy of Cancer. 3(S2). 3 indexed citations
7.
Hassan, Namir J., Giovanna Bossi, Katherine J. Adams, et al.. (2014). Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma. Cancer Research. 74(19_Supplement). 2900–2900. 1 indexed citations
8.
Aleksic, Milos, Nathaniel Liddy, Peter Molloy, et al.. (2012). Different affinity windows for virus and cancer‐specific T‐cell receptors: Implications for therapeutic strategies. European Journal of Immunology. 42(12). 3174–3179. 183 indexed citations
9.
Liddy, Nathaniel, Peter Molloy, Alan Bennett, et al.. (2010). Production of a Soluble Disulfide Bond-Linked TCR in the Cytoplasm of Escherichia coli trxB gor Mutants. Molecular Biotechnology. 45(2). 140–149. 9 indexed citations
10.
Varela‐Rohena, Angel, Peter Molloy, Steven M. Dunn, et al.. (2008). Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor. Nature Medicine. 14(12). 1390–1395. 197 indexed citations
11.
Zhao, Yangbing, Alan Bennett, Zhili Zheng, et al.. (2007). High-Affinity TCRs Generated by Phage Display Provide CD4+ T Cells with the Ability to Recognize and Kill Tumor Cell Lines. The Journal of Immunology. 179(9). 5845–5854. 164 indexed citations
12.
Sami, Malkit, P.J. Rizkallah, Peter Molloy, et al.. (2007). Crystal structures of high affinity human T-cell receptors bound to peptide major histocompatibility complex reveal native diagonal binding geometry. Protein Engineering Design and Selection. 20(8). 397–403. 47 indexed citations
13.
Molloy, Peter, et al.. (2005). Soluble T cell receptors: novel immunotherapies. Current Opinion in Pharmacology. 5(4). 438–443. 29 indexed citations
14.
Strachan, Gillian, et al.. (2003). Anti-mesotrione single chain antibody fragments derived using either phage display or via hybridoma technology: selection, characterization and stabilization. Food and Agricultural Immunology. 15(2). 115–125. 1 indexed citations
15.
Molloy, Peter, William J. Harris, Gillian Strachan, Colin Watts, & Charles Cunningham. (1998). Production of soluble single-chain T-cell receptor fragments in Escherichia coli trxB mutants. Molecular Immunology. 35(2). 73–81. 11 indexed citations
16.
Molloy, Peter, et al.. (1995). Separation and concentration of bacteria with immobilized antibody fragments. Journal of Applied Bacteriology. 78(4). 359–365. 37 indexed citations
17.
Molloy, Peter, et al.. (1995). Expression and purification strategies for the production of single-chain antibody and T-cell receptor fragments inE. coli. Molecular Biotechnology. 4(3). 239–245. 4 indexed citations
18.
McGregor, Duncan, Peter Molloy, Charles Cunningham, & William J. Harris. (1994). Spontaneous assembly of bivalent single chain antibody fragments in Escherichia coli. Molecular Immunology. 31(3). 219–226. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Annelise Vuidepot Breakdown of academic impact, for papers by Nadine Bizouarne Breakdown of academic impact, for papers by Verena Rubio‐Godoy Breakdown of academic impact, for papers by Guillaume Stewart-Jones Breakdown of academic impact, for papers by Sean C. Yoder Breakdown of academic impact, for papers by Christina Furebring Breakdown of academic impact, for papers by Thomas Meyer Breakdown of academic impact, for papers by Xuezhi Cao Breakdown of academic impact, for papers by Claudia Lemmel
Rankless by CCL
2026